The aim of this study is to assess the epidemiological and clinical features of patients diagnosed with COVID-19 in Kazakhstan at the onset of the pandemic.
There is a paucity of data available on the epidemiological and clinical characteristics of
coronavirus disease 2019 (COVID-19) in Kazakhstan. While a global effort in search for
effective treatments and vaccines against COVID-19 is in effect, it is important that high
quality and up-to-date information be available from a broad variety of populations on the
dynamics of infection. This is especially important in regions where, due to resource
shortage, epidemiologic surveillance may have gaps. To address the current gaps, medical
records will be obtained for patients with confirmed COVID-19 during the first months of the
pandemic (February-April 2020). The epidemiologic and clinical features including the
demographics, clinical manifestation, laboratory parameters, radiologic assessments and
clinical outcomes will be analyzed. The results of this study will facilitate the clinical
management of COVID-19 patients in Kazakhstan and ultimately inform the ongoing efforts to
curb the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the
region.
Inclusion Criteria:
- Laboratory confirmation of SARS-CoV-2 infection by polymerase chain reaction.
Semey Medical University
Semey, East Kazakhstan, Kazakhstan